As a Senior Investment Manager for Health at Oost NL, Björn Schaap focuses on early-stage life sciences companies. He holds an MSc from Rotterdam School of Management and an Executive Master in M&A and Valuation. He actively supports portfolio companies developing novel treatments for conditions like Parkinsons disease.
He is passionate about supporting what he calls "echt ondernemerschap" (true entrepreneurship) to help bring new medical treatments from the lab to patients.
Björn Schaap
Senior Investment Manager at Oost NL
Zwolle, Overijssel, Netherlands
Overview
Topics They Care About
Life Sciences VC
As a Senior Investment Manager at Oost NL, he actively finds and funds promising early-stage companies in the health and biotech sectors.
Therapeutic Innovation
He is directly involved with companies developing novel treatments, including Mair Therapeutics (neurodegenerative disorders) and Tagworks (oncology).
AI in Healthcare
Serves as a shareholder representative for Aiosyn, a company that develops AI-powered algorithms for pathology diagnostics.
Media Appearances
Björn has no verified media appearances
Work History
1-2024
Senior Investment Manager at Oost NL
9-2019 - 1-2024
Investment Manager at Oost NL
3-2025
Shareholder Representative at Mair Therapeutics
1-2024
Board Observer at Delta Life Science
2-2022
Shareholder Representative at Aiosyn
1-2022
Board Observer at River BioMedics
Education
2010 - 2011
Master of Science (MSc) from Rotterdam School of Management, Erasmus University
2017 - 2019
Executive Master of M&A and Valuation from University of Groningen
More Information
Social Presence :
Prographics :
Exp : 6
Location : Zwolle, Overijssel, Netherlands
Job Level : Middle
Designation : Senior Investment Manager at Oost NL
